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The term registry is widely used to refer to any database storing clinical information collected as a byproduct of patient care. Despite
the use of this single characterizing term (registry), these databases exist in various forms and support functions ranging from biomedical
informatics and clinical research, to public health, epidemiology and evidence-based clinical practice. This ambiguous terminology
impacts the ability to locate and learn about speciﬁc types of registries; the goal of this research project was to develop a more useful
categorization scheme for registries. We thoroughly analyzed peer-reviewed publications related to registries. From our ﬁndings, we cre-
ated a detailed deﬁnition for registries in healthcare (medical data registries, or MDRs) and outlined a set of characteristics common to
all such MDRs. This framework, MDR-OK, comprises ﬁve distinguishing features of registries, and is intended to provide a clear under-
standing of MDRs as a functional variety of databases, as well as to provide a framework for evaluation and categorization of registries
and other data systems.
 2008 Elsevier Inc. All rights reserved.
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Recent reports by the Institute of Medicine demonstrate
the potential impact of clinical data analysis as a method
to improve our healthcare system and to establish quality
benchmarks [1,2]. Indeed, databases are important and
widely used tools in science—including modern medical
practice and clinical research [3]. A database has been
deﬁned as a structured repository of data that allows for
ongoing data collection, modiﬁcation, and retrieval [4,5].
Articles using the term database abound in the literature—
with more than 88,000 title hits on MEDLINE as of July
2007.
In many cases, researchers with a desire to assess a
group of patients want a ‘‘registry” of these patients. A
PubMed search for the term ‘‘registry” in July 2007
returned almost 43,000 hits. A well-cited operational deﬁ-1532-0464/$ - see front matter  2008 Elsevier Inc. All rights reserved.
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According to MeSH, registries are the ‘‘systems and pro-
cesses involved in the establishment, support, management,
and operation of registers [sic], e.g., disease registers.” This
deﬁnition appropriately expands the notion of a registry
(synonymous and used interchangeably with register by
MeSH) to involve both the environment (through systems
and processes that must be managed) and the interaction of
that environment with a speciﬁc disease or therapy. How-
ever, it does not adequately articulate the speciﬁc diﬀer-
ences between simple databases and more sophisticated
databases around which systems or processes can be con-
structed to improve their use for benchmarking or out-
comes research [6,7]. It is these more sophisticated
databases (and the systems that support them) that are
often designated registries.
The ambiguity regarding the unique requirements of
registries is fueled by the variety of data repositories
described using this single term. The history of registries
is centuries old [8], and though modern computerized reg-
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and manually tabulated systems, the terms used to describe
them have not changed signiﬁcantly. The deﬁnition of a reg-
istry, most recently described in 2002 by Arts et al. [3], is
based on work dating from 1949 to 1991 [9–12]: ‘‘a system-
atic collection of a clearly deﬁned set of health and demo-
graphic data for patients with speciﬁc health
characteristics, held in a central database for a predeﬁned
purpose.”AlthoughArts’ deﬁnition characterizes important
features of registries, there are several reasons to pursue a
more thorough deﬁnition and understanding of these data
systems. Arts’ deﬁnition does not distinguish a database
from a registry [13–15], nor does it adequately elucidate all
important registry traits including those characterized in
the MeSH deﬁnition of the term. For example, data collec-
tion approaches and data models vary widely among dat-
abases; however, the use of a registry to store patient data
should imply at a minimum the need for a standard set of
procedures to appropriately manage security and data pri-
vacy. Such procedural requirements may be pre-speciﬁed,
as is the case with the privacy and security rules speciﬁed
by the Health Insurance Portability and Accountability
Act (HIPAA), under United States Federal Law [16,17], or
they may be less stringent in other countries. How these pro-
cedures are implemented also may vary among registries,
but the functional endpoint should be the same.
Numerous computerized registries have been presented,
but not reproducibly characterized in the literature, begin-
ning in the 1970s with the trauma registry at Cook County
Hospital [18,19] and the total joint arthroplasty registry at
the Mayo Clinic [20]. Since then, projects described as reg-
istries have greatly increased in number. For example, Swe-
den saw nearly a twofold increase in national registries in
just 4 years, jumping from 40 to 70, between 2001 and
2005 [21–23]. The goal of this project was to devise a frame-
work for deﬁning and functionally characterizing registries
of the type now prevalent in the literature under that head-
ing. Such a framework will allow researchers to better
describe, design, and understand data systems, and eventu-
ally to conduct more accurate literature searches if our
terms become standard. Likewise, physicians and health-
care administrators can apply this framework to evaluate
registries for use in medical practice or in hospital settings.
2. Methods
This project was conducted in three phases, largely fol-
lowing the immersion/crystallization process used in qual-
itative research [24]. This process features ‘‘the analyst’s
prolonged immersion into and experience of the text and
then emerging, after concerned reﬂection, with an intuitive
crystallization of the text.”
In the ﬁrst phase, we constructed a reference list of medi-
cal data registry (MDR)-related papers from the peer-
reviewed literature. In the second phase, we reviewed each
paper to determine how well it ﬁt the deﬁnition of registry
that had been proposed by Arts in 2002 [3]. During thisimmersion phase, we also noted the presence and absence
of characteristics identiﬁed as important by the authors,
including processes for data collection, storage, retrieval,
and speciﬁc constraints based on the type of data. In the ﬁnal
step (crystallization), we developed a framework consisting
of a distilled or summarized set of frequently cited character-
istics described in manuscripts about registries. We used this
framework to construct an inclusive deﬁnition for what we
term amedical data registry (MDR), which is a subset of reg-
istry as previously discussed but speciﬁc formedical data.We
also generated our scoring and categorization framework.
Each phase of this project is described in detail below.
2.1. Phase I: identiﬁcation of references
Published studies potentially related to registries were
identiﬁed in MEDLINE using PubMed and Ovid search
engines. We also used Google Scholar for broad Internet
searches. A title search was run using ‘‘registry OR register
OR regist#.” This query was modiﬁed independently and
grouped using AND ‘‘medical”, ‘‘clinical”, ‘‘disease”,
‘‘database”, ‘‘data repository”, and ‘‘computerized” to cre-
ate our initial reference set (IREF). Using the original
search query and independently including the keywords
‘‘evaluation”, ‘‘implementation”, ‘‘design”, and ‘‘review”,
we identiﬁed a second set of articles. These primary refer-
ence sets were limited to English articles that had been pub-
lished in peer-reviewed journals with available online
abstracts. Subsequently, we expanded the references to
include papers from relevant citations. These cited sources
were retrieved and manually entered into the IREF.
2.2. Phase II: preliminary review
One of the authors (BCD) initially read the abstracts of
the review articles to identify papers not directly related to
the registry (e.g., an article that used a registry to assess
immunization compliance but did not describe the charac-
teristics of the registry). We reviewed the remaining articles
completely and identiﬁed 15 papers (Table 1) that reviewed
and discussed general registry characteristics, as well regis-
try construction and development. From this review set
(REV), we identiﬁed an initial group of ‘‘registry” charac-
teristics from which we created a working framework for
an objective, qualitative evaluation of the IREF.
We then reviewed the abstracts from the IREF and
excluded any article not clearly discussing a registry or reg-
istries. Each remaining article in the IREF was reviewed by
both authors in face-to-face meetings to determine the
presence or absence of the initial characteristics identiﬁed
in the REV. In cases where an IREF article did not
describe the registry in any detail, we actively searched
for this information in MEDLINE or from the Internet.
If no further information could be found, we excluded
the paper and the registry from further review. This process
identiﬁed 96 papers describing 42 speciﬁc ‘‘registry”
projects.
Table 1
Articles referenced for general discussion of medical data registry design, evaluation and implementation
Title [citation] Author Year
Evaluation and Implementation of Public Health Registries [9] Solomon, D.J. 1991
Immunization Registries in the United States: Implications for the Practice of Public Health in a
Changing Health Care System [56]
Wood, D. 1999
Building a patient registry from the ground up [57] White, B. 1999
Clinical data repositories: an overview Guyer, S. 2000
National and regional registries: what good are they? [13] Dyke, C.K. 2000
Are data from clinical registries of any value? [14] Alpert, J.S. 2000
Deﬁning and improving data quality in medical registries: a literature review, case study and generic framework [3] Arts, D.G. 2002
Improving Primary Care for Patients with Chronic Illness [27] Bodenheimer, T. 2002
Using Computerized Registries in Chronic Disease Care [25] Metzger, J. 2004
Using Clinical Information Technology in Chronic Disease Care: Expert Workshop Summary [26] Mittman, R. 2004
Using Computerized Medical Databases to Measure and to Improve the Quality of Intensive Care [58] Rubenfeld, G.D. 2004
Database Production and Maintenance [59] Engh, C.A. 2004
Introduction/overview on clinical registries [15] Gladman, D.D. 2005
Critical Features for a Successful Implementation of a Diabetes Registry [28] Gabbay, R.A. 2005
The rationale for a spine registry [51] Roder, C. 2006
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Based on the 15 review papers (REV) that discussed
design, implementation, and utilization of MDRs, the two
authors developed a candidate set of MDR characteristics.
We subsequently reviewed the 96 papers discussing the 42
data projects and iteratively reﬁned (crystallized) our set of
characteristics. In this process, we used software (Excel) to
label articles based on the registry characteristics identiﬁed
or omitted. We generalized some characteristics (e.g., able
to support a uniﬁed, centralized data storage approachbecame
mergeable) or added new characteristics that were not ini-
tially generated from the REV papers. Every reference was
reviewed at least two times by the ﬁrst author, and at least
once by the second author. The REV articles were reviewed
twice because they did not discuss speciﬁc registry projects,
and therefore the presence or absence of ‘‘new” characteris-
tics was not identiﬁed by further review. On the other hand,
the remainder of IREF articles were reviewed four times to
assess for the presence or absence of characteristics identiﬁed
through subsequent iterations of the crystallization proto-
col. We grouped characteristics, ultimately arriving at
six—ﬁve for deﬁnition and one for categorization—that
appeared frequently in the IREF. We created a detailed def-
inition of each of the six composite characteristics based on
all referenced papers.We assigned descriptive and numerical
values to eachMDR characteristic to create the framework,
as shown inTable 2. Finally,we evaluated each of the 42 data
systems for these six characteristics to test our framework
(Table 3).
3. Results
3.1. MDR framework details
Our initial query in phase I returned a total of over 500
references. In phase II, this number was reduced signiﬁ-
cantly by review of abstracts for immediate relevance, fol-lowed by exclusion of articles with incomplete data.
Ultimately, 96 references (Table 3) remained for 42 unique
clinical data systems (multiple references were used for
most data projects). During phase III, we evaluated these
data systems looking for the six registry characteristics pre-
viously discussed (Table 3). Four clinical data projects did
not contain all ﬁve characteristics in our deﬁnition (Table
4a). These four projects collected a cross-section of data
without an association of these data over time. The remain-
ing 38 registries possessed the ﬁve critical characteristics,
which appear to uniquely distinguish registries from simple
databases or other non-registry data repositories. These
characteristics relate to key design principles underlying
MDRs as discussed below. For a database to meet our def-
inition of a registry, all ﬁve of the following MDR charac-
teristics must be present (i.e., score of one or greater for
each trait):
 (M)ergeable data: Data from multiple users and from
all patients in the database are combined to create an
aggregate set of data. An aggregate dataset supports
numerous functions including assessment of procedural
utilization and outcomes, physician performance and
patient health trends. The ability to merge data into a
centralized dataset can be either present {1} or absent
{Ø}.
 (D)ataset standardized: The same set of characteristics
is collected for each patient in the repository. This pro-
cess establishes a well-populated data matrix of the
aggregate dataset. If all patients contribute data for
the same variables, comparisons between patients and
to the aggregate population will be possible. A standard-
ized dataset can be either present {1} or absent {Ø}.
 (R)ules for data collection: A systematic and prospective
data collection protocol is established. Systematic collec-
tion optimizes standardization of the dataset, which is
critical to functional data collection endeavors (like
MDRs) as described above. Prospective requires pre-
Table 2
MDR-OK categorization protocol
Variable Deﬁned characteristic Value
Mergeable data M Data stored in format that allows a user/researcher to create a single
aggregate and queriable dataset for research and patient care purposes
Ø. No
1. Yes
Dataset standardized D The same data are collected for all patients/records in a registry Ø. No
1. Yes
Rules for data collection R A set of characteristics are deﬁned prior to the collection of data.
These data are collected in a systematic and prospective manner
Ø. No
1. Yes
Observations associated over time O Database is designed so that each patient is identiﬁed in the registry
as a single continuous record for storage of longitudinal data
Ø. No
1. Yes
Knowledge of outcomes K Follow-up must be obtained to assess outcomes or manage patient care Ø. None
1. Passive
2. Active
Inclusion principle — The characteristic that is common to all patients in an MDR DZ = chronic disease
TH = acute/interventional
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lection of these data; this process minimizes data omis-
sion and confounding bias. These rules for data
collection protocol can be either present {1} or absent
{Ø}.
 (O)bservations associated over time: In the collection
and storage of longitudinal patient data, a systems pro-
tocol links follow-up data for individual patients to their
unique record in the registry. This is an important tech-
nical extension of the follow-up protocol required of
MDRs. Without such a process, follow-up associations
for individual patients and the aggregate are not possi-
ble. Observation associated over time for individual
patients can be either present {1} or absent {Ø}.
 (K)nowledge about patient outcomes: Follow-up data
are collected for all patients in the database. In order
to provide useful data for any purpose, a registry should
collect data that can evaluate the results of each case.
For practitioners, these data can be used in self-evalua-
tion of healthcare delivery and evaluation of patient
health trends over time. For researchers, follow-up data
are essential to evaluate the impact of therapy on both
short and long-term outcomes. Knowledge of outcomes
can be either active (e.g., computerized reminder system,
patient outreach, etc.) {2}, passive (i.e., additional
entries collected during subsequent encounters) {1} or
absent {Ø}.
The sixth characteristic (inclusion principle) will be dis-
cussed in the next subsection.3.2. MDR domains
A qualitative assessment of the 38 deﬁnitive registries
disclosed two broad domains of MDR focus: chronic dis-
eases, independent of therapy; and therapeutic interven-
tions, such as treatment for acute coronary events or
surgical procedures. The sixth component of our frame-work, called inclusion principle (IP), describes the charac-
teristic of a registry for grouping into either domain. The
IP is the distinguishing feature of a registry; it describes
the medical trait that is common to the patient population
of an MDR (e.g., a diabetes registry only records data for
diabetic patients). The inclusion principles of diﬀerent reg-
istries were easily grouped by unambiguous inherent simi-
larities, allowing us to categorize registries into two
domains; either chronic disease (DZ-MDR) or therapeutic
(TH-MDR) (Table 4b).
As the ﬁnal component of our study, we examined
numerous secondary design and functional characteristics
of the 38 deﬁnitive registries. The design features are
related to the data storage architecture and intended usage
(e.g., outcomes research versus patient data management).
The functional characteristics primarily involve the appli-
cation of data stored in the registry (e.g., reminder system
for follow-up appointments). Based on our qualitative
assessment, we found that MDRs within each domain—
DZ-MDR versus TH-MDR—had similar secondary char-
acteristics. In general, chronic disease-speciﬁc MDRs were
designed for integration into the workﬂow of the clinician
and used for patient management. In contrast, therapy-
based registries tended to have research goals and were
not as integrated into clinic workﬂow. Table 5 summarizes
important secondary characteristics and their presence or
absence in several well-discussed registries from each
domain.4. Discussion
We have designed MDR-OK under the premise that cer-
tain data system features make a repository more func-
tional for a chosen purpose (e.g., research, patient
management, etc.). We deﬁne a medical data registry
(MDR) as system functioning in patient management or
research, in which a standardized and complete dataset
including associated follow-up is prospectively and system-
Table 3
Deﬁning characteristics of MDRs
Table 4a
Projects not satisfying MDR-OK criteria
Database name Meets registry deﬁnition M D R O K Inclusion principle MDR-OK score
ADHERE [60] No 1 1 1 Ø 1 Hospitalized for acute heart failure 4
CRB [75] No 1 1 1 Ø 1 Renal biopsy 4
ENACT [76,77] No 1 1 1 Ø Ø Acute coronary syndromes 3
NPR [55] No 1 1 1 Ø Ø All patients, on hospital discharge 3
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disease or therapeutic intervention. This deﬁnition builds
upon that proposed by Arts [3], and makes the important
distinction that registries are a functional subset of dat-
abases (i.e., all registries are databases, but not all dat-abases are registries). In making this distinction we have
described ﬁve registry-deﬁning characteristics (MDR-
OK), which when present will make a data system (registry
by our deﬁnition) maximally functional for a variety of
purposes. Therefore, it is not appropriate to use the terms
Table 4b
Evaluation of MDRs using MDR-OK scoring protocol and inclusion principle categorization
Database name M D R O K Inclusion principle MDR-OK score and inclusion principle
Family Care Network [57] 1 1 1 1 1 Chronic disease 5, DZ
Puget Sound Diabetes [106] 1 1 1 1 1 Chronic disease 5, DZ
Mayo Diabetes [89] 1 1 1 1 2 Chronic disease 6, DZ
MGH/DMA Diabetes [29,30] 1 1 1 1 1 Chronic disease 5, DZ
NEBR [40] 1 1 1 1 1 Chronic disease 5, DZ
REACH [107,108] 1 1 1 1 1 Chronic disease 5, DZ
RIAT [110,111] 1 1 1 1 1 Chronic disease 5, DZ
AWESOME [33,63–65] 1 1 1 1 1 Therapeutic 5, TH
AVID [66–68] 1 1 1 1 1 Therapeutic 5, TH
AORI THA [59] 1 1 1 1 1 Therapeutic 5, TH
BRB [69,70] 1 1 1 1 1 Therapeutic 5, TH
COHERE [35,71] 1 1 1 1 1 Therapeutic 5, TH
CONCOR [54,126] 1 1 1 1 1 Therapeutic 5, TH
CASS [32,72–74] 1 1 1 1 2 Therapeutic 6, TH
DRSB [42] 1 1 1 1 1 Therapeutic 5, TH
ERA-EDTA [78,79] 1 1 1 1 1 Therapeutic 5, TH
EVENT [80] 1 1 1 1 1 Therapeutic 5, TH
Finnvasc [81–83] 1 1 1 1 1 Therapeutic 5, TH
Finnish Arthroplasty [48,49,84] 1 1 1 1 1 Therapeutic 5, TH
GRACE [85–88] 1 1 1 1 1 Therapeutic 5, TH
IRNR [36] 1 1 1 1 1 Therapeutic 5, TH
Mayo Arthroplasty [20,46] 1 1 1 1 2 Therapeutic 6, TH
NA-PCM [53] 1 1 1 1 1 Therapeutic 5, TH
NEON [92,93] 1 1 1 1 1 Therapeutic 5, TH
NIROO [94] 1 1 1 1 1 Therapeutic 5, TH
Norwegian Arthroplasty [44,96,97] 1 1 1 1 1 Therapeutic 5, TH
NorKar [22,98] 1 1 1 1 1 Therapeutic 5, TH
NPTR [99,100] 1 1 1 1 1 Therapeutic 5, TH
NSN [37,101–103] 1 1 1 1 1 Therapeutic 5, TH
PREMIER [104,105] 1 1 1 1 1 Therapeutic 5, TH
REIN [109] 1 1 1 1 1 Therapeutic 5, TH
SOJRR [45] 1 1 1 1 1 Therapeutic 5, TH
Spine Tango [112–114] 1 1 1 1 1 Therapeutic 5, TH
Swedish Cataract [21,115–117] 1 1 1 1 1 Therapeutic 5, TH
Swedish Hip Replacement [43,47,50,118,119] 1 1 1 1 1 Therapeutic 5, TH
SwedVasc [120,121] 1 1 1 1 1 Therapeutic 5, TH
Swedish Spine [23,39,122–124,127] 1 1 1 1 1 Therapeutic 5, TH
UKBOR [52,125] 1 1 1 1 1 Therapeutic 5, TH
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potentially more value to physicians, healthcare adminis-
trators, and researchers. In choosing a data system for
research, patient management, or other functions, our
scoring system and taxonomy can be a guide in shopping
for a registry from private companies marketing proprie-
tary data collection systems designed for practitioners or
researchers. Likewise, registry developers may use this
framework to model MDRs and associated policies/proce-
dures. Finally, the literature should beneﬁt from accurate
and appropriate use of terminology and categorization of
registries provided by the MDR-OK framework.
This manuscript represents the most thorough deﬁnition
of a registry to date and describes the ﬁrst published proto-
col for classifying and categorizing medical data registries
based on design and functional characteristics. There are
three implications of this work. First, as discussed above,
a database should only be termed an MDR when all ﬁve
MDR-OK characteristics are present. Second, all registryand non-registry databases may be scored and classiﬁed
using the MDR-OK protocol. Finally, an MDR’s function
and approach to data collection appear to be closely tied to
what we have termed the inclusion principle (IP). This
inherent characteristic requires little interpretation and
appears to predict many secondary aspects of a registry.
By grouping similar IPs, we have established two MDR
domains and have demonstrated that registries within each
domain tend to share similar secondary features.
In general, chronic disease-speciﬁc (DZ) MDRs focus
on patient management and the use of treatment guidelines
to improve quality of care by targeting high-risk patients
and utilizing physician/patient reminder systems to
improve follow-up care [25–27]. These registries may be
useful for population-wide healthcare improvement by
enabling hypothesis generation or retrospective (pre–post)
studies. These registries can utilize outcomes data to assess
disease status depending on the IP. For example, a physi-
cian using a diabetes MDR might look at a patient’s
Table 5
MDR-OK, inclusion principle and secondary registry characteristics
Database name Inclusion principle M D R O K Clinical
support
system
Physician
feedback
Based on
guidelines
Patient
management
Reminder
system
Outcomes
research
Chronic disease
Unspeciﬁed* [27] Chronic disease* X X X X X X X X X X
Unspeciﬁed* [25] Chronic disease* X X X X X X X X X X
Unspeciﬁed* [26] Diabetes X X X X X X X X X X
Mayo Diabetes[89] Diabetes X X X X X X X X X X
Puget Sound Diabetes[106] Diabetes X X X X X X X X X X X
MGH/DMA Diabetes [29,30] Diabetes X X X X X X X X X
Family Care Network [57] Diabetes X X X X X X X X X X X
RIAT [110,111] Hypertension X X X X X X X X
Acute/interventional
Unspeciﬁed* [51] Spine* X X X X X X
Unspeciﬁed* [58] Intensive Care* X X X X X X X X
Swedish Cataract [21,115–117] Cataract X X X X X X
Mayo Arthroplasty [20,46] Arthroplasty X X X X X X X X X
AORI THA [59] Arthroplasty X X X X X X X
NSN [37,38,101–103] Spine X X X X X X X X
Swedish Spine [23,39,122–124,127] Spine X X X X X X X X
Swedish Hip [43,47,50,118,119] Arthroplastyssssss X X X X X X X
Finnish Arthroplasty [48,49,84] Arthroplasty X X X X X X
SwedVasc [120,121,128] Vascular Surgery X X X X X X X
Spine Tango [112–114] Spine X X X X X X X
GRACE [85–88,129] Acute coronary events X X X X X X
* Indicates paper did not discuss a particular registry project, but rather general concepts or principles of registries.
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quency of HbA1c measurements performed by physicians;
insurance companies, researchers, and administrators can
assess physician compliance with standard guidelines (i.e.,
HbA1c measured every six months) [31]. Finally, long-term
results of HbA1c measurements can be used as an out-
comes measure to assess the impact of care [28]. Conse-
quently, DZ-MDRs function in patient and physician
assessment, and as healthcare management tools. Our ﬁnd-
ings for the functions real-world DZ-MDRs, when catego-
rized as such by the MDR-OK protocol, are both
consistent and expound upon those proposed by Wagner
in his chronic illness model [27].
On the other hand, therapeutic (TH) MDRs collect data
about patients who are acutely ill or are receiving a speciﬁc
therapy. These registries evaluate the outcomes of acute
illness and how therapies impact outcomes. Many
TH-MDRs evaluating care for severe, acute events use
mortality as the outcome measure (e.g., myocardial infarc-
tion) [32–36]. Numerous other measures are found in the
cited references, including validated outcomes metrics
(e.g., SF-36) [37–39], complications rates [21,40–43], or
the need for revision surgery [44–50]. TH-MDRs serve as
tools supporting the practice of evidence-based medicine,
allowing researchers to identify therapies associated with
the best outcomes. Indeed, TH-MDRs have been success-
fully used by oncologists to optimize chemotherapy for
decades. Additionally, TH-MDRs can be used for assess-
ment of diagnostic and procedural utilization [51], as well
as ongoing demographic and epidemiological evaluations[52–54]. Finally, TH-MDRs sometimes function in a
patient management capacity. An example includes the
Mayo Arthroplasty registry [46], which sends reminders
to physicians to follow-up at appropriate intervals follow-
ing surgery. However, many TH-MDRs may be unusable
for this type of patient management because data entry
occurs in batches long after treatment is complete, despite
prospective collection of data. This storage approach limits
the usefulness of the registry in clinic work-ﬂow or short-
term healthcare delivery, but does not compromise the reg-
istry for its intended outcomes research purpose.
Of note, this framework may also be useful for non-reg-
istry database classiﬁcation, as demonstrated in Table 4a.
Consider a non-MDR database like the self-described Nor-
wegian Patient ‘‘Registry” (NPR) [55], which we scored as
{TH M1, D1, R1, OØ, KØ}. The NPR is a good exam-
ple of an administrative database, which records discharge
diagnoses and several other demographic features of
patients, but no follow-up information. Although the
NPR has an atypical inclusion principle—hospital dis-
charge—it might still be categorized using MDR-OK as a
therapeutic non-MDR database, with the inclusion princi-
ple as the ‘‘therapy” of ‘‘inpatient admission” regardless of
treatment provided. When classiﬁed as such, the database
should have some research functionality, which it does in
population and disease epidemiology. However, a lack of
follow-up precludes its signiﬁcant use in clinical research.
Using the MDR-OK framework to classify various data-
base projects, both registry and non-registry, may serve
many purposes. First, the framework may provide more
1016 B.C. Drolet, K.B. Johnson / Journal of Biomedical Informatics 41 (2008) 1009–1020speciﬁc results from PubMed searches if our terminology
becomes standard for authors. Second, it is likely that
other aspects of MDRs, including data entry approaches,
sustainability models, or analytic methods, may be tied to
one or more of these characteristics; though this associa-
tion has not been demonstrated in this analysis. Third, this
framework may provide a better understanding of a partic-
ular MDR’s capabilities and intended use—which will ben-
eﬁt other attempts at comparing MDRs or learning about
the technical requirements for MDRs with speciﬁc design
speciﬁcations.
We have noted similar design features and applications
of MDRs within either of the two IP domains. As previ-
ously mentioned, there is some overlap in function, but
the primary applications of each registry type are distinct.
We note that there is a diﬀerence between the registry per
se and the applications of a registry. Applications rely on
data, and MDRs can be a great source for these data. In
our secondary analysis, we have included several additional
features of registries, which are most appropriately deﬁned
as peripheral applications because they make use of regis-
try data but are not required of a registry by MDR-OK.
Two applications in particular, a clinical support system
and a clinician feedback protocol, were present in most
proper registries (Table 5). We feel these applications rep-
resent important utilization of registry data; however, the
presence of these applications is not necessary by deﬁnition
for a data system to be deﬁned as a registry. We believe
that a good registry should function as a clinical support
system: data collected for the registry should be distributed
to staﬀ and physicians as part of normal clinical workﬂow.
Second, registries should provide data as feedback to phy-
sicians submitting information to the dataset. Physicians
should be informed of their adherence to standard-of-care
guidelines, their patients’ outcomes; individual physician or
oﬃce can also be compared to the aggregate dataset. Many
of the registries we studied utilized these applications, and
this additional feature is particularly useful in the practice
of evidence-based medicine.
5. Limitations and future work
Our study has several limitations, primarily related to
our methodology of gathering data regarding the speciﬁc
registry projects. First, inter-rater reliability cannot be
assessed from our immersion–crystallization protocol;
though both authors contributed to the review process.
Second, we did not conduct a systematic literature review.
Thus, we may have omitted articles discussing registries
that were only described as databases or other data sys-
tems. Since our review protocol focused on ﬁnding pub-
lished descriptions of ‘‘registry” projects—speciﬁcally the
design, evaluation and implementation of self-described
registries—we did not include articles in the IREF discuss-
ing databases that may have been MDR-OK-consistent
registries but were not self-described as a ‘‘registry.” There-
fore, it is possible that characteristics of MDRs wereexcluded in our scoring and categorization framework
due to incomplete sampling of the literature. However,
we believe that our thorough examination of the many reg-
istry projects included in the IREF made our examination
broad enough that we have included all vital registry fea-
tures. Moreover, our review protocol did include a single
reading of manuscripts discussing database projects that
we ultimately excluded from IREF as non-registry accord-
ing to the authors’ descriptions. Finally, we suggest that
this limitation of our study, which is due to inexact or
improper terminology prevalent in the literature, is pre-
cisely the problem that we try to resolve with the MDR-
OK framework.
A third limitation of our research is incomplete data
regarding the registries within our study. As mentioned in
our methods, we conducted our evaluation based on infor-
mation available in the literature and online regarding each
individual MDR. We did not attempt to contact authors or
registry coordinators in order to further examine the sec-
ondary characteristics of all MDRs in the IREF. However,
data were available for the six MDR-OK characteristics for
all 38 registries and four databases examined. Likewise,
suﬃcient data regarding important secondary features were
available to support our preliminary ﬁndings and warrant
further investigation (Table 5). Future research will focus
on more thoroughly evaluating these secondary character-
istics and their association with either chronic disease or
therapeutic MDRs. We will conduct literature review and
directly contact registry projects to study prototype regis-
tries within each category of our framework. Now that
we have deﬁned important parameters and categorized
MDRs, we would like to understand the features that make
one registry more successful than another of the same vari-
ety. Lastly, there is little current research about how regis-
tries functioning as clinical support tools impact physicians
and patients. We are in the process of adopting a registry
and studying its eﬀects on patient satisfaction, provider
attitudes about the system, and long-term outcomes assess-
ment to improve quality of care.
6. Conclusion
We have conducted a thorough review of the literature
discussing medical data registries (MDRs). This review
has resulted in a framework, MDR-OK, that may be used
to better distinguish an MDR from a non-registry data-
base, to deﬁne the term ‘‘registry”, and to score and catego-
rize various data systems including MDRs. Our deﬁnition
and categorization framework is the most thorough to
date, and should provide clarity regarding choice of termi-
nology in the literature. Researchers may be able to use this
framework to better describe and understand their data
systems, and eventually to conduct more accurate literature
searches about MDRs. Although more useful to research-
ers and health information managers, physicians, and
healthcare administrators can use our results to evaluate
registries for use in medical practice or in hospital settings.
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